News

Growth stocks can help you grow a small sum of money into a large nest egg for retirement. While stock selection plays a crucial role in your returns, many of the best growth stocks are brands and

Salesforce (NYSE: CRM) has failed to impress investors with its artificial intelligence capabilities.

*Stock prices used were the afternoon prices of Nov. 30, 2025. The video was published on Dec

Software developer GitLab (NASDAQ: GTLB) is seeing its stock "git" crushed after reporting strong earnings, but so-so guidance last night. Heading into the report, analysts forecast GitLab would

My portfolio of top stocks to buy has outperformed major indexes in 2025.

*Stock prices used were the afternoon prices of Nov. 30, 2025. The video was published on Dec. 2, 2025.

Continue reading

So

Two of the biggest behemoths in retail are Walmart (NYSE: WMT) and Costco Wholesale (NASDAQ: COST). They both offer essential day-to-day products, including groceries, and a diverse mix of

CoreWeave (NASDAQ: CRWV) stock has soared this year as deal after deal has been announced for the products it sells. CoreWeave holds the data center cloud computing capacity tech firms are clamoring

I'm the type of person who really does not mind working hard. You know what I do mind? Paying taxes.

Of course, I realize that to some degree, taxes are inevitable. But I try my best to minimize my

There are a lot of bad ideas on the slippery path of a downward spiral. AMC Entertainment (NYSE: AMC) has gone through its share of misfires, as the stock has plunged 99.7% since notching an

Remember when Wall Street considered Lucid Group (NASDAQ: LCID) a possible future competitor to Tesla (NASDAQ: TSLA)? It may seem like ancient history now, but at the height of the early 2020s "EV

Uber (NYSE: UBER) has demonstrated excellent growth in all the critical metrics investors appreciate.

*Stock prices used were the afternoon prices of Nov. 30, 2025. The video was published on Dec

Cybersecurity specialist Zscaler (NASDAQ: ZS) had been performing impressively on the stock market -- at least, until Nov. 25 when it released results for its fiscal 2026 first quarter (ended Oct

It is becoming clearer how the battle lines will be drawn in the war over artificial intelligence (AI) supremacy. On one side, you have Alphabet (NASDAQ: GOOG) and its vertically integrated AI

It would be a massive understatement to say that artificial intelligence (AI) has consumed a large part of the business and investing world over the past couple of years. It's essentially

On November 14, New York City-based Commodore Capital disclosed a new position in Amylyx Pharmaceuticals (NASDAQ:AMLX), acquiring nearly 4.1 million shares valued at approximately $55 million

In the artificial intelligence (AI) era, the companies striking gold are building and training AI models, integrating AI capabilities to enhance existing software (like Meta Platforms), and creating

New York City-based Commodore Capital fully exited its position in Scholar Rock Holding Corporation (NASDAQ:SRRK), selling approximately 1.5 million shares in the third quarter, according to a

The past two years have been challenging for Novo Nordisk (NYSE: NVO). The Denmark-based pharmaceutical company has dealt with worse-than-expected earnings, clinical-trial setbacks, and significant

If you have to make required minimum distributions (RMDs), you must do so even if you don't need the cash right away. But that cash doesn't have to sit in your bank account. Just as quickly as you

New York City-based Commodore Capital established a new position in Terns Pharmaceuticals (NASDAQ:TERN) in the third quarter, acquiring 5.7 million shares valued at approximately $42.8 million

Meme stocks have drawn considerable attention in investment circles. Instead of focusing on rising profits or attractive valuations, such stocks are often driven by hype coming from social media

Stockholders of electrical utility NextEra Energy (NYSE: NEE) were feeling juiced this fall as shares of the massive power generation company surged more than 20% between mid-September and late

Chief Corporate Development Officer Peter Rahmer disclosed the sale of 40,529 shares of Relay Therapeutics (NASDAQ:RLAY) in multiple open-market transactions on Oct. 28 and Oct. 29, 2025, as

Shares of investing platform Robinhood Markets (NASDAQ: HOOD) dropped 13% in November, according to data provided by S&P Global Market Intelligence. The company reported excellent third-quarter

New York City-based Commodore Capital boosted its stake in Relay Therapeutics (NASDAQ:RLAY) by nearly 3.7 million shares in the third quarter, contributing to an estimated $42.6 million net position

Despite the many advancements in personal finance technology, I'll admit that I often fall back on my old-school budgeting notebook to figure out where my household stands. In fact, as I write this,